Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels
- PMID: 37535039
- PMCID: PMC10442869
- DOI: 10.1097/COH.0000000000000809
Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels
Abstract
Purpose of review: The success of HIV-1 eradication strategies relies on in-depth understanding of HIV-1-infected cells. However, HIV-1-infected cells are extremely heterogeneous and rare. Single-cell multiomic approaches resolve the heterogeneity and rarity of HIV-1-infected cells.
Recent findings: Advancement in single-cell multiomic approaches enabled HIV-1 reservoir profiling across the epigenetic (ATAC-seq), transcriptional (RNA-seq), and protein levels (CITE-seq). Using HIV-1 RNA as a surrogate, ECCITE-seq identified enrichment of HIV-1-infected cells in clonally expanded cytotoxic CD4+ T cells. Using HIV-1 DNA PCR-activated microfluidic sorting, FIND-seq captured the bulk transcriptome of HIV-1 DNA+ cells. Using targeted HIV-1 DNA amplification, PheP-seq identified surface protein expression of intact versus defective HIV-1-infected cells. Using ATAC-seq to identify HIV-1 DNA, ASAP-seq captured transcription factor activity and surface protein expression of HIV-1 DNA+ cells. Combining HIV-1 mapping by ATAC-seq and HIV-1 RNA mapping by RNA-seq, DOGMA-seq captured the epigenetic, transcriptional, and surface protein expression of latent and transcriptionally active HIV-1-infected cells. To identify reproducible biological insights and authentic HIV-1-infected cells and avoid false-positive discovery of artifacts, we reviewed current practices of single-cell multiomic experimental design and bioinformatic analysis.
Summary: Single-cell multiomic approaches may identify innovative mechanisms of HIV-1 persistence, nominate therapeutic strategies, and accelerate discoveries.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
None.
Figures
References
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF, Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science 278(5341) (1997) 1295–300. - PubMed
-
-
Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD, Recovery of replication-competent HIV despite prolonged suppression of plasma viremia, Science 278(5341) (1997) 1291–5.
*The above are the three back-to-back studies defining HIV-1 latent resevoir.
-
-
-
Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF, Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells, Nat Med 9(6) (2003) 727–8.
*The above two studies both measured the half-life of the HIV-1 latent reservoir to be around 44 months.
-
Publication types
MeSH terms
Substances
Grants and funding
- R61 DA047037/DA/NIDA NIH HHS/United States
- R01 DA051906/DA/NIDA NIH HHS/United States
- UM1 AI164565/AI/NIAID NIH HHS/United States
- UM1 DA051410/DA/NIDA NIH HHS/United States
- UM1 AI164570/AI/NIAID NIH HHS/United States
- R01 AI145164/AI/NIAID NIH HHS/United States
- R33 DA047037/DA/NIDA NIH HHS/United States
- U01 DA053628/DA/NIDA NIH HHS/United States
- U54 AI170856/AI/NIAID NIH HHS/United States
- P50 AI150464/AI/NIAID NIH HHS/United States
- P01 AI169768/AI/NIAID NIH HHS/United States
- R01 AI174863/AI/NIAID NIH HHS/United States
- R01 AI141009/AI/NIAID NIH HHS/United States
- R37 AI147868/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials